Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate

Headache as a Prognostic Factor for COVID-19. Time to Re-evaluate

Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hy...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:SN comprehensive clinical medicine 2020, Vol.2 (12), p.2509-2510
Hauptverfasser: Martelletti, Paolo, Bentivegna, Enrico, Luciani, Michelangelo, Spuntarelli, Valerio
Format: Artikel
Sprache:eng
Schlagworte:
Covid-19
Medicine
Medicine & Public Health
Topical Collection on COVID-19
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Headache occurs in only about 13% of patients within the cohort of presenting COVID-19 symptoms. The hypothesis that such a painful symptomatic picture could be considered a prognostic factor for COVID-19 positive evolution or its trend of severity, or the co-generation of hyposmia/anosmia and/or hypogeusia/ageusia, needs robust epidemiological data, punctual pathophysiological demonstrations, and a detailed comparative analysis on drug–drug interactions (DDIs).
ISSN:2523-8973
2523-8973
DOI:10.1007/s42399-020-00657-7